BATS BZX Real-Time Price
As of 3:48pm ET
| +0.19 / +2.59%|
The 2 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 10.25, with a high estimate of 11.50 and a low estimate of 9.00. The median estimate represents a +35.94% increase from the last price of 7.54.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.